- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1/A IPO registration
- 1.1 EX-1.1
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 5.1 EX-5.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10.1 EX-10.10.1
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.27 EX-10.27
- 10.28 EX-10.28
- 10.29 EX-10.29
- 10.30 EX-10.30
- 10.31 EX-10.31
- 10.32 EX-10.32
- 10.33 EX-10.33
- 10.37 EX-10.37
- 10.38 EX-10.38
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of Bioventus Inc.of our report dated April 19, 2016, except for the effects of the revision discussed under the caption ‘May 2016 Revision’ in Note 19 to the consolidated financial statements of Bioventus LLC, as to which the date is May 26, 2016, and except for the effects of the revision discussed under the caption ‘July 2016 Revision’ in Note 19 to the consolidated financial statements, as to which the date is July 19, 2016, which appears in the Registration Statement on Form S-1. We also consent to the reference to us under the heading “Experts”in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
July 19, 2016